The Brief Brief Science
what we just learned about everything.
Science — briefly, then briefly again · tbb.ceo
listen tothe daily 0:00 –:––
/daily ·24 OCT 2026 ·SATURDAY ·2 MIN READ ·6 STORIES

Personalised medicine had a good weekend

A melanoma mRNA vaccine, a PTSD brain-stimulation trial, and a malaria entry mechanism provide the headlines; the physics bench meanwhile removes a hard constraint from power electronics.

01 / The Day

SATURDAY 24 OCT 2026, ranked

06

Moderna mRNA Vaccine Nearly Halves Melanoma Recurrence

A Phase 2b/3 trial of Moderna's personalised mRNA melanoma vaccine combined with Keytruda has shown a 44% reduction in recurrence or death at the three-year mark versus Keytruda alone, extending the lead from earlier results.

  • 44% relative risk reduction in recurrence-free survival at 36 months
  • Vaccine codes for up to 34 neoantigens personalised to each patient's tumour
  • Moderna expects Phase 3 data in 2028; regulatory path under discussion with FDA
Why it mattersThis is the trial that, if it holds, makes personalised cancer vaccines a standard-of-care question — the three-year durability data is the metric oncologists were waiting for.

Malaria Parasite's Red Cell Break-In Caught on Camera

Researchers using cryo-electron tomography have captured the first molecular-resolution video of Plasmodium falciparum using its RON2-AMA1 junction complex to drill through the red blood cell membrane, revealing a previously hidden structural rearrangement that could be targeted by next-generation vaccines.

  • First sub-nanometre resolution of the invasion mechanism in action
  • Structural rearrangement in RON2 not seen in prior X-ray crystallography models
  • Three vaccine-candidate binding sites identified from the new structure
Why it mattersMalaria kills 600,000 people a year and the existing RTS,S vaccine tops out at about 56% efficacy — a structural map of the invasion step is the kind of data that unlocks new vaccine generations.

Personalised Brain Stimulation Hits 68% PTSD Remission

A sham-controlled trial of closed-loop deep brain stimulation, where stimulation parameters adapt in real time to each patient's neural biomarkers, achieved a 68% remission rate in treatment-resistant PTSD — more than double the rate seen with open-loop stimulation.

  • 32 patients, double-blind crossover design with six-month follow-up
  • System uses amygdala activity as a continuous feedback signal
  • Remission defined as PCL-5 score falling below clinical threshold at both 3 and 6 months
Why it mattersTreatment-resistant PTSD has almost no approved options that work this well — the closed-loop design is the mechanism insight that makes this more than a fluke.

Japan's Kikai Supervolcano Is Refilling With Magma

Seismic tomography and GPS uplift data from Japan's Kyushu island reveal that the Kikai caldera's magma reservoir is refilling at a rate roughly three times higher than the pre-2024 baseline, though volcanologists say an eruption is neither imminent nor likely on any human planning timescale.

  • Uplift at 38 mm per year versus 12 mm baseline measured from 2014-2024
  • Magma reservoir estimated at 5,000 cubic kilometres — one of the largest known
  • No seismic precursors suggesting imminent eruptive activity detected
Why it mattersKikai's last super-eruption roughly 7,300 years ago caused a regional collapse; understanding the system's current state is basic due diligence for a country of 125 million people.

Exercise Slows Both Motor and Cognitive Parkinson's Decline

A meta-analysis of 34 randomised controlled trials covering 2,400 Parkinson's patients confirms that structured aerobic exercise slows motor symptom progression at 12 months and, for the first time with pooled evidence, also slows cognitive decline — measured by MoCA score — at the same timepoint.

  • Effect size 0.61 for motor outcomes (moderate-to-large), 0.38 for cognition (small-to-moderate)
  • High-intensity interval training showed larger effects than moderate-intensity steady-state
  • Authors note exercise is the only intervention showing dual motor-cognitive effect in Parkinson's
Why it mattersExercise costs nothing compared to any clinical intervention and this is now the clearest pooled evidence that it fights both disease dimensions at once — the mechanism likely involves BDNF and dopamine pathway preservation.

Semiconductor Breakthrough Unlocks Extreme-Voltage Power Electronics

Researchers have demonstrated an aluminium nitride semiconductor device capable of blocking 20 kilovolts of electrical stress while maintaining switching speeds fast enough for grid-scale converters — removing a longstanding design constraint that forced engineers to stack lower-voltage devices in series.

  • 20 kV blocking voltage with less than 5 µA leakage current at room temperature
  • Device fabricated on a 4-inch wafer using standard CVD tooling
  • Applications include direct AC-DC conversion for HVDC grid interconnects without intermediate transformers
Why it mattersHigh-voltage power electronics is a bottleneck for the grid transition — every long-distance HVDC link and offshore wind converter needs this kind of device, and right now you need stacks of silicon carbide to approximate it.
Be subscriber #022 the weekly ten, every friday by email · no spam · unsubscribe anytime
Past days

The Daily Archive